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Sports is broadly integrated in our society. In early child-
hood specific sports can become a fascination, especially
when the young person appears to be talented. At a certain
stage only a select group gets the chance to become elite
athletes and turn their hobby into a career. By that time,
in most professional sports, several different interests and
responsibilities begin to play a role. In that situation, it’s
only logical that we perform some form of cardiovascu-
lar screening to evaluate the risk of sudden cardiac arrest
in the athlete; it has a tremendous impact when it occurs.
At the same time, however, important questions come up:
Can we reliably predict the future for someone who has
been identified with a cardiac disorder and, especially in
the case of asymptomatic disorders, should this person be
disqualified from competition, weighing the possible risks
on life-threatening cardiovascular events on the one hand
and the unique career perspectives on the other? Although
sudden cardiac arrest is the leading cause of death among
young athletes, we know little about the exact occurrence
of sudden cardiac arrest due to structural heart disease in
professional sports participants. Results of a large retrospec-
tive study performed in Canada (the Rescu Epistry cardiac
arrest study, 3,825 persons included, 12–45 years of age)
were recently published, reporting an incidence of 0.76
cases of sudden cardiac arrest during competitive sports
per 100,000 athlete-years, with 43.8% of the athletes sur-
viving until they were discharged from the hospital [1].
Based on the fact that in the 16 cases of sudden cardiac ar-
rest that occurred during competitive sports only 2 cases of
hypertrophic cardiomyopathy were identified, the authors
concluded that sudden cardiac death during participation
in competitive sports is rare and more than 80% of cases
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would not have been identified with systematic preparticipa-
tion screening. In this issue of the Netherlands Heart Journal
Jorstad and Mosterd considerately debate the pros and cons,
respectively, of preparticipation screening in young athletes
[2, 3].
Recently, the European Heart Rhythm Association pub-
lished a position paper on preparticipation cardiovascular
evaluation for athletic participants to prevent sudden death
[4]. The purpose of the position paper was to review the sci-
entific evidence regarding the appropriate diagnostic meth-
ods to identify the cardiac conditions at risk in the athletic
population. The paper further discussed the role of the dif-
ferent tests in the context of preparticipation cardiovascular
evaluation. Furthermore, the consensus opinions relative to
the most efficient preparticipation screening to improve safe
sports participation according to current scientific evidence
are described [4].
Currently, there are still important knowledge gaps in
the optimal preparticipation screening programmes for elite
sports participants and therefore it remains extremely diffi-
cult for the physician to interfere and eventually disqualify
an athlete from competition. This decision has a huge, life-
changing, impact on the individual athlete, their families
and surroundings. Disqualifying an athlete from competi-
tion does have legal, financial, and mental consequences
[5]. Therefore, as physicians we have to ask ourselves: Is
the outcome of this decision in line with the Hippocratic
oath, ‘Primum non nocere’ (first, do no further harm)? Are
we in fact affecting the well-being of the individual athlete?
Although the incidence of sudden cardiac arrest is rare,
we must continue with joint research to better predict the
risks in athletes and minimise the occurrence of these tragic
events in the future.
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